Vildagliptin: A new oral treatment for type 2 diabetes mellitus — Uses, Dosage, Side Effects & Safety

Drug class: DPP-4 Inhibitors

At a glance: Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is an oral antidiabetic agent indicated for the treatment of type 2 diabetes mellitus. It enhances glycemic control by increasing active incretin hormone levels, thereby stimulating insulin release and suppressing glucagon secretion in a glucose-dependent manner. Common side effects should be discussed with a healthcare provider. Regular monitoring of renal function is advisable during treatment.

Overview

{"side_effects":{"common_mild_effects":"Most people tolerate vildagliptin well. Common mild side effects include headache, dizziness, mild gastrointestinal discomfort (such as nausea or diarrhea), and upper respiratory tract infections. ","warning_signs":["Persistent abdominal pain (possible pancreatitis)","Unexplained muscle pain or weakness","Yellowing of the skin or eyes (jaundice)","Severe skin reactions (rash, blistering)","Signs of allergic reaction (swelling, difficulty breathing)"],"emergency_and_serious":"Seek immediate medical attention if you experience symptoms of pancreatitis (severe abdominal pain, vomiting), liver problems (dark urine, yellow skin/eyes), severe allergic reactions (swelling of face/tongue/throat, difficulty breathing), or severe skin reactions (Stevens-Johnson syndrome, blistering, peeling skin). "},"before_taking":{"contraindications":"Do not use vildagliptin if you have a known hypersensitivity to vildagliptin or any of its components, or if you have a history of serious liver disease. ","precautions":["Inform your doctor if you have a history of pancreatitis, heart failure, or kidney or liver problems.","Use with caution in elderly patients or those taking other medications that may affect the liver."]},"how_to_take":{"general_instructions":"Take vildagliptin exactly as prescribed by your healthcare provider, usually once or twice daily. It can be taken with or without food. ","adult_dosing":"The typical starting dose is 50 mg once or twice d

Clinical information

[{"title":"Mechanism of Action","content":"Vildagliptin is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). By inhibiting DPP-4, vildagliptin increases endogenous levels of incretin hormones (GLP-1 and GIP), which enhance glucose-dependent insulin secretion and suppress glucagon release. This results in improved glycemic control, particularly postprandial glucose levels, without significant risk of hypoglycemia when used as monotherapy. "},{"title":"Detailed Pharmacokinetics","content":"Absorption: Rapidly absorbed after oral administration, with peak plasma concentrations reached within 1.7 hours. Bioavailability is approximately 85%. Distribution: Moderate plasma protein binding (~9.3%). Metabolism: Extensively metabolized in the liver, primarily via hydrolysis. Elimination: Excreted mainly via the kidneys (85% as metabolites, 23% unchanged). Elimination half-life is approximately 3 hours. "},{"title":"Clinical Contraindications & Precautions","content":"Contraindicated in patients with hypersensitivity to vildagliptin or any component of the formulation, and in those with severe hepatic impairment. Use with caution in patients with a history of pancreatitis, heart failure (NYHA class III-IV), or moderate to severe renal impairment. Regular monitoring of liver function is recommended due to rare cases of hepatic dysfunction. "},{&quo

Therapeutic uses

• Type 2 diabetes mellitus glycemic control, alone or in combination with metformin, sulfonylureas, or insulin
• Type 2 Diabetes Mellitus

Common side effects

• Headache
• Nasopharyngitis
• Upper respiratory tract infection
• Diarrhea
• Dizziness
• Hypoglycemia (when used with sulfonylurea)
• Pancreatitis
• Liver enzyme elevations

Drug interactions

• Increased hypoglycemia risk when combined with sulfonylureas or insulin
• ACE inhibitors may increase the risk of angioedema when combined with DPP-4 inhibitors
• No clinically significant interaction expected with most CYP450-metabolized drugs, as vildagliptin is primarily eliminated by hydrolysis

Contraindications

• Significant hepatic impairment
• Type 1 diabetes mellitus or diabetic ketoacidosis
• Known hypersensitivity to vildagliptin

Precautions & warnings

Liver function should be monitored periodically, as rare cases of hepatic dysfunction have been reported. Cases of acute pancreatitis have been reported with DPP-4 inhibitors as a class; discontinue promptly if pancreatitis is suspected. Risk of hypoglycemia is increased when combined with insulin or sulfonylureas, which may need dose reduction.

Pregnancy

Use during pregnancy only if clearly needed, as insulin is generally preferred for glycemic control in pregnancy.

Key safety information

• Not for type 1 diabetes
• Monitor for potential interactions with other medications

Frequently Asked Questions about Vildagliptin: A new oral treatment for type 2 diabetes mellitus

What is vildagliptin used for?

Vildagliptin is used to help control blood sugar levels in adults with type 2 diabetes, either alone or in combination with other diabetes medications.

How does vildagliptin work?

Vildagliptin increases the levels of incretin hormones, which stimulate the pancreas to release more insulin and reduce glucose production by the liver, especially after meals.

Can vildagliptin cause hypoglycemia?

Vildagliptin alone has a low risk of causing hypoglycemia, but the risk increases when used with sulfonylureas or insulin.

Is vildagliptin safe in pregnancy or breastfeeding?

Vildagliptin is not recommended during pregnancy or breastfeeding due to limited safety data. Consult your healthcare provider for alternatives.

What should I do if I miss a dose?

Take the missed dose as soon as you remember, unless it is almost time for your next dose. Do not double up doses.

Can I drink alcohol while taking vildagliptin?

Alcohol can affect blood sugar control and should be limited or avoided while taking vildagliptin.

What are the serious side effects of vildagliptin?

Serious side effects include pancreatitis, liver problems, severe skin reactions, and allergic reactions. Seek immediate medical attention if you experience these.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.